These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 7887634)

  • 1. [Progress of chemotherapy in adult acute leukemia].
    Ohno R
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in the treatment of adult acute myeloid leukemia].
    Ohno R
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1053-8. PubMed ID: 9239156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of 58 patients with acute leukemia].
    Sasaki A; Tsukaguchi M
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1303-7. PubMed ID: 1503484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in the treatment of acute myelogenous leukemia].
    Dohy H; Kyo T
    Gan To Kagaku Ryoho; 1989 May; 16(5):1976-81. PubMed ID: 2658836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent advances on the treatment of acute childhood leukemia].
    Fujimoto T
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1059-65. PubMed ID: 9239157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive chemotherapy for acute leukemia relapsed after bone marrow transplantation: a second chance?
    Sica S; Di Mario A; Pagano L; Etuk B; Salutari P; Leone G
    Acta Haematol; 1992; 87(4):173-5. PubMed ID: 1519431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
    Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
    J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer curable by chemotherapy: acute myelogenous leukemia].
    Ohno R; Tanimoto M; Morishita Y; Morishima Y; Saito H; Yokomaku S; Nagai T; Kodera Y; Minami S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1329-34. PubMed ID: 2730046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective analysis of elderly patients > or = 60 years of age with acute leukemia].
    Tabata M; Yoshida M; Izumi T; Kawano C; Kuribara R; Toshima M; Omine K; Takatoku M; Uchida M; Kirito K; Miyazato A; Takahashi H; Hoshino M; Terui Y; Tomizuka H; Otsuki T; Shimizu R; Tsunoda J; Muroi K; Furukawa Y; Amemiya Y; Imagawa S; Komatsu N; Suzuki T; Miura Y
    Rinsho Ketsueki; 1998 Mar; 39(3):176-84. PubMed ID: 9577640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
    Kobayashi T; Miyawaki S; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Ohmoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Matsuoka A; Tomonaga M; Ohno R
    J Clin Oncol; 1996 Jan; 14(1):204-13. PubMed ID: 8558199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of conventional chemotherapy and short-term intensive chemotherapy in adult acute myeloid leukemia].
    Ohshima T
    Rinsho Ketsueki; 1989 Aug; 30(8):1175-7. PubMed ID: 2601028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-term intensive consolidation chemotherapy in the treatment of acute non-lymphocytic leukemia].
    Nagata K; Hatanaka T; Ito T; Saito M; Ono Y; Kamiya O; Ohara K
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1079-81. PubMed ID: 1626944
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute non-lymphocytic leukemia with alternating non-cross resistant chemotherapy.
    Kyo T; Dohy H
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1641-52. PubMed ID: 3247827
    [No Abstract]   [Full Text] [Related]  

  • 14. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
    De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
    Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
    Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive chemotherapy for acute leukemia relapsed after transplantation.
    Sica S; Salutari P; Di Mario A; D'Onofrio G; Etuk B; Leone G
    Leuk Lymphoma; 1994 Sep; 15(1-2):131-4. PubMed ID: 7858490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
    Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
    Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of acute myelogenous leukemia: results of combination chemotherapy with cytarabine, daunorubicin and 6-mercaptopurine.
    Ko WS; Chen LM; Hwang SH; Chao TY; Wang CC; Kao WY; Lee WC; Hwang WS
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Sep; 48(3):185-9. PubMed ID: 1657335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
    Nara N
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved survival for patients with acute myelogenous leukemia.
    Mitus AJ; Miller KB; Schenkein DP; Ryan HF; Parsons SK; Wheeler C; Antin JH
    J Clin Oncol; 1995 Mar; 13(3):560-9. PubMed ID: 7884416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.